Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
XASE:INFU
INFU Stock Chart & Stats
$9.60
-$0.03(-0.37%)
At close: 4:00 PM EST
$9.60
-$0.03(-0.37%)
Day’s Range― - ―
52-Week Range$4.61 - $11.04
Previous CloseN/A
Volume2.40K
Average Volume (3M)143.18K
Market Cap
$195.68M
Enterprise Value$197.60M
Total Cash (Recent Filing)$3.19M
Total Debt (Recent Filing)$3.43M
Price to Earnings (P/E)12.7
Beta1.82
Next Earnings
Apr 30, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding20,215,158
10 Day Avg. Volume153,430
30 Day Avg. Volume143,176
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)3.23
Price to Sales (P/S)1.29
P/FCF Ratio7.77
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue1.38
Enterprise Value/Gross Profit2.46
Enterprise Value/Ebitda7.80
Forecast
1Y Price Target
$16.25Price Target Upside69.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.41
Revenue Forecast (FY)$148.06M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe Company showed notable progress in gross margin improvement of 122 basis points Y/Y and AEBITDA margin improvement of 282 basis points Y/Y.
Operating Cash FlowOperating cash flow was $20.5M in 2024, an 82% increase Y/Y.
Bears Say
EarningsEPS of $0.04 was below our estimate and consensus of $0.08 and $0.09, respectively.
RevenueRevenue came in below our forecast and consensus due to delays in onboarding new wound care initiatives as the Company looks to improve referral processes with newer partners.
InfuSystem Holdings News
INFU FAQ
What was InfuSystem Holdings, Inc.’s price range in the past 12 months?
InfuSystem Holdings, Inc. lowest stock price was $4.61 and its highest was $11.04 in the past 12 months.
What is InfuSystem Holdings, Inc.’s market cap?
InfuSystem Holdings, Inc.’s market cap is $195.68M.
When is InfuSystem Holdings, Inc.’s upcoming earnings report date?
InfuSystem Holdings, Inc.’s upcoming earnings report date is Apr 30, 2026 which is in 54 days.
How were InfuSystem Holdings, Inc.’s earnings last quarter?
InfuSystem Holdings, Inc. released its earnings results on Feb 24, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.072 by $0.028.
Is InfuSystem Holdings, Inc. overvalued?
According to Wall Street analysts InfuSystem Holdings, Inc.’s price is currently Undervalued.
Does InfuSystem Holdings, Inc. pay dividends?
InfuSystem Holdings, Inc. does not currently pay dividends.
What is InfuSystem Holdings, Inc.’s EPS estimate?
InfuSystem Holdings, Inc.’s EPS estimate is 0.03.
How many shares outstanding does InfuSystem Holdings, Inc. have?
InfuSystem Holdings, Inc. has 20,215,158 shares outstanding.
What happened to InfuSystem Holdings, Inc.’s price movement after its last earnings report?
InfuSystem Holdings, Inc. reported an EPS of $0.1 in its last earnings report, beating expectations of $0.072. Following the earnings report the stock price went up 13.456%.
Which hedge fund is a major shareholder of InfuSystem Holdings, Inc.?
Currently, no hedge funds are holding shares in INFU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InfuSystem Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.25 (69.27% Upside)
$16.25 (69.27% Upside)
Blogger Sentiment
Bullish
INFU Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 62.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $18.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.4%
Last 30 Days ▲ 7.9%
Last 30 Days ▲ 7.9%
News Sentiment
Bullish
Bullish news 79%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
55.37%
12-Months-Change
Fundamentals
Return on Equity
11.54%
Trailing 12-Months
Asset Growth
-1.64%
Trailing 12-Months
Company Description
InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
INFU Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a largely positive operational and financial momentum: revenue and record adjusted EBITDA growth, stronger margins, robust cash generation, reduced net debt and substantial liquidity. Management acknowledged short-term headwinds including a deliberate revenue reduction from a restructured GE contract, temporary ERP implementation costs and some reimbursement/regulatory uncertainty (ChemoMouthpiece). However, management framed the contract restructuring and system upgrades as strategic moves that will improve profitability and scalability, and highlighted significant product-led growth (notably wound care/PCDs) and expected ERP-related cost savings (~$2 million annually). On balance, the positive performance metrics, liquidity and clear path to margin/cost improvements outweigh the near-term challenges and uncertainties.View all INFU earnings summariesINFU Stock 12 Month Forecast
Average Price Target
$16.25
▲(69.27% Upside)
Technical Analysis
Orasure Technologies
―
Utah Medical Products
―
REPRO-MED Systems
―
Sanara MedTech
―
Sharps Technology, Inc.
―
Ownership Overview
10.12% Insiders
14.67% Mutual Funds
17.64% Other Institutional Investors
50.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---